Patrick Lucy
Vermögen: 58 427 $ am 31.05.2026
Vermögen: 58 427 $ am 31.05.2026
Patrick K.
Lucy was the founder of Pelican, Inc., founded in 2009, serving as Chief Business Officer & Senior Vice President from 2017 to 2020.
Mr. Lucy is currently Chief Executive Officer & Director at Wheeler Bio, Inc. since 2024 and Chairman at Dyadic International, Inc. since 2024.
Former positions include President & Chief Executive Officer at Roslin Cell Therapies Ltd., Director-Business Development at Collaborative BioAlliance Inc & Collaborative Smithfield Corp from 1999 to 2002, Director-Business Development at Dowpharma from 2002 to 2009, Principal at The Dow Chemical Co., Principal at Repligen Corp.
from 1991 to 1998, Manager-Validation & Capital Project at Lonza Biologics Plc from 1998 to 1999, and President & Chief Operating Officer at Lykan Bioscience LLC in 2021.
Education includes undergraduate studies at Villanova University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2026 | 72.311 ( 0,2 % ) | 58 427 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Vorsitzender | 28.03.2024 |
Wheeler Bio, Inc.
Wheeler Bio, Inc. Pharmaceuticals: OtherHealth Technology Operates as a contract development and manufacturing organization that discovers & develops process for biopharmaceutical companies | Vorstandsvorsitzender | 09.10.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFENEX INC. | Vorstandsvorsitzender | 03.08.2017 |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Manufactures and distributes chemical, pharmaceutical & biopharmaceutical products | Corporate Officer/Principal | 01.01.2009 |
Collaborative BioAlliance Inc & Collaborative Smithfield Corp
Collaborative BioAlliance Inc & Collaborative Smithfield Corp Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical drugs | Corporate Officer/Principal | 01.01.2002 |
Lonza Biologics Plc
Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies | Corporate Officer/Principal | 01.01.1999 |
| REPLIGEN CORPORATION | Corporate Officer/Principal | 01.01.1998 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Dyadic International, Inc.
Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products | Health Services |
Lonza Biologics Plc
Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies | Commercial Services |
Collaborative BioAlliance Inc & Collaborative Smithfield Corp
Collaborative BioAlliance Inc & Collaborative Smithfield Corp Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical drugs | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Manufactures and distributes chemical, pharmaceutical & biopharmaceutical products | Process Industries |
Pelican Inc
Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Lykan Bioscience LLC
Lykan Bioscience LLC Pharmaceuticals: MajorHealth Technology Develops cell and gene therapies | Health Technology |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Health Technology |
Wheeler Bio, Inc.
Wheeler Bio, Inc. Pharmaceuticals: OtherHealth Technology Operates as a contract development and manufacturing organization that discovers & develops process for biopharmaceutical companies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen